-
BPGbio to Present New Data on Novel Glioblastoma Therapies at SNO 2024
21 Nov 2024 12:03 GMT
… highlight BPM31510 and BRG399—potential glioblastoma multiforme (GBM) therapies that were … BPM31510 significantly improved survival in glioma implanted mice and rats compared … , and improve survival in rat glioma models.
“Standard cancer treatments that …
-
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
21 Nov 2024 12:16 GMT
… treatment of adult patients with glioblastoma multiforme (GBM).
Optune Gio … type of brain cancer called glioblastoma multiforme (GBM) in adult … of adult patients with glioblastoma, non-small cell lung … in the treatment of glioblastoma, non-small cell lung …
-
Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
21 Nov 2024 12:16 GMT
… Treating Fields (TTFields) therapy for glioblastoma at the 29th Annual Scientific … with isocitrate dehydrogenase (IDH)-mutant glioblastoma.
Novocure’s SNO 2024 Data … demonstrate efficacy for treatment of glioblastoma
Presenting Author: Moshe Giladi, Novocure …
-
Combination Therapy Does Not Extend Survival in Glioblastoma
20 Nov 2024 20:18 GMT
… to treat recurrent brain tumors), glioblastoma is extremely treatment-resistant, and … months.
Approximately one-third of glioblastoma tumors express MGMT protein promoter … of 447 patients diagnosed with glioblastoma with MGMT promoter hypermethylation who …
-
Brain-penetrating molecule might offer a route to treat glioblastoma tumours
20 Nov 2024 20:08 GMT
Southern University of Science and Technology; School of Medicine & School of Public Health and Emergency Management;
Shenzhen, Guangdong, China
Southern University of Science and Technology, School of Medicine
-
Dose-Escalated Proton Beam Therapy in Glioblastoma Using 18F-DOPA PET Imaging
20 Nov 2024 17:01 GMT
… older patients with newly diagnosed glioblastoma.
They enrolled patients aged ≥65 … diagnosed WHO grade 4 malignant glioblastoma and an Eastern Cooperative Oncology … profile in patients with older glioblastoma.
Source: thelancet.com/journals …
-
Enhancing Transfection Efficacy in Glioma Cells: A Comparison of Microfluidic versus Manual Polypropylenimine Dendriplex Formation
20 Nov 2024 13:38 GMT
… vitro gene delivery efficacy in glioma cancer cells, in comparison … was evaluated on C6 rat glioma cells plasmid DNA encoding β- … hours before treatment, on C6 glioma cells. Blue: nuclei stained … was assessed in C6 rat glioma cells. Dendriplexes formed using …
-
Siren Biotechnology names SRN-101 as lead asset for high-grade gliomas
19 Nov 2024 21:44 GMT
-
GenesisCare offers Optune Gio® for grade 4 Glioma patients
19 Nov 2024 13:02 GMT
… newly diagnosed WHO Grade 4 Glioma patients, meaning they can access …
-
Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan Drug and Rare Pediatric Disease Designations from the FDA
18 Nov 2024 16:00 GMT
… patients with high-grade gliomas and pediatric-type diffuse … high-grade gliomas, respectively, some of … patients with high-grade gliomas. Siren Biotechnology’s Approach … treatment of high-grade gliomas but also has transformative …
About
© 1995-2024